2023 annual financial data
Spruce Biosciences 2023 Revenue growth
Direct answer
Revenue growth was 413.7%.
Operating income was -51,993,000 USD and net income was -47,919,000 USD.
Operating cash flow was -33,275,000 USD.
Get free Spruce Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 10,089,000 USD
- Operating income
- -51,993,000 USD
- Net income
- -47,919,000 USD
- Operating cash flow
- -33,275,000 USD